In continuation of last week’s essay, Type 2 is the most common type of ED in men under 45. It is also the only type that has ...
UVA is conducting a clinical trial exploring the potential of low-intensity shockwave therapy to address erectile dysfunction by promoting new blood vessel growth and tissue repair. The federal Food ...
According to the National Institutes of Health (NIH), erectile dysfunction (ED) affects about 30 million men in the United States. While it’s not unusual to have difficulty maintaining an erection ...
Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. John Smith, DO, a urologist at University of Utah Health, addresses the barriers to ...
AMSTERDAM — A noninvasive EEG-based test may help predict the risk of sexual dysfunction for patients considering treatment with antidepressants, a new study showed. The Loudness Dependence of ...
LONDON, April 23 (Reuters) - British drug development firm Vectura Group Plc said on Monday a phase two clinical study on its inhaled erectile dysfunction (ED) product had been successful. "It is ...
Men have been offered a simple test that takes less than 60 seconds and explains your risk of suffering from erectile dysfunction. Experts say knowing your risk is vital as it can be an early warning ...
UNDATED (WKRC) - A dietary supplement was recalled after testing showed that it contains an erectile dysfunction drug. Testing revealed that the supplement Wonder Pill had an undeclared ingredient, ...
LONDON, April 23 (Reuters) - British drug development firm Vectura Group Plc said on Monday a phase two clinical study on its inhaled erectile dysfunction product had been successful. Vectura said in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results